Jamal Rahima, Ghannoum Marc, Naud Jean-Francois, Turgeon Pierre-Paul, Leblanc Martine
Department of Medicine, Maisonneuve-Rosemont Hospital , University of Montreal.
Division of Nephrology , Verdun Hospital.
NDT Plus. 2008 Oct;1(5):322-5. doi: 10.1093/ndtplus/sfn075. Epub 2008 Jun 23.
Background. Controversy exists with volume resuscitation using crystalloids or colloids. Renal dysfunction has been reported with some colloids and osmotic agents, but remains poorly defined. Patient. We report the case of a 67-year-old male who had normal kidney function at baseline and who developed anuric ARF in relation to the administration of >10 litres of 10% pentastarch. A renal biopsy confirmed hydropic changes in tubular cells compatible with colloid-induced damage. Conclusion. This case demonstrates that hydroxyethyl starch preparations may be associated with acute kidney injury, and one should carefully consider their use, especially in patients with pre-existing renal dysfunction. Osmotic tubular cell lesions may be long lasting and irreversible.
背景。关于使用晶体液或胶体液进行容量复苏存在争议。已有报道称某些胶体液和渗透剂会导致肾功能障碍,但对此仍定义不清。病例。我们报告一例67岁男性病例,其基线肾功能正常,因输注超过10升10%的羟乙基淀粉而发生无尿性急性肾衰竭。肾活检证实肾小管细胞出现水样变性,符合胶体诱导的损伤。结论。该病例表明羟乙基淀粉制剂可能与急性肾损伤有关,应谨慎考虑使用,尤其是对于已有肾功能不全的患者。渗透性肾小管细胞损伤可能持续时间长且不可逆。